New Study Conducted at Sheppard Pratt Finds Psilocybin-Assisted Therapy May Reduce Chronic Suicidal IdeationMorningStar·May 26 at 12:50 PMMNMD0.00%CMPS-2.33%
FDA Moves To Fast-Track Psychedelic Therapies For Mental Healthrttnews·Apr 24 at 04:50 PMATAI+0.28%CYBN0.00%
Trump Order To Accelerate Treatments For Serious Mental Illnessrttnews·Apr 20 at 06:37 AMCMPS-2.33%MNMD0.00%
Trump: Accelerate access to research on psychedelic drugsWallstreetcn·Apr 18 at 08:14 AMGHRS-1.13%MNMD0.00%
Women's health startup Midi Health hit a $1 billion valuation. Its founder says AI changed everything.businessinsider·Apr 14 at 11:02 PMMNMD0.00%FBT-3.47%
11:03 ETSonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systemsprnewswire·Mar 24 at 10:05 AMSOND0.00%BBH-1.98%
NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver DiseaseThe newswire.ca·Mar 11 at 06:30 AMPBE-2.73%XBI-3.31%
Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile of CMND-100 in Ongoing Phase I/IIa Clinical Trial | CMND Stock NewsStockTitan·Feb 8 at 11:17 PMPBE-2.73%IXJ-1.07%
Clearmind Medicine partners to develop intranasal MEAI for addiction & CNS disorders, boosting bioavailability & clinical progress.Unusual Whales·Feb 6 at 06:56 AMIXJ-1.07%XBI-3.31%
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Short Interest UpdateMarket Beat·Jan 19 at 10:19 PMMNMD0.00%
Mind Medicine MindMed | 10-Q: FY2025 Q3 Revenue: USD 0Earnings Watch·Nov 6, 2025 at 04:06 PMMNMD0.00%DFTX-3.03%
